Skip to main content

Table 3 The characteristics of subjects with and without overall satisfaction with the treatment.

From: Alternative vs. conventional treatment given on-demand for gastroesophageal reflux disease: a randomised controlled trial

Patients' characteristics

Overall satisfied

Statistics

 

Yes

No

 

Number of subjects

58

19

 

Male (no)

32 (55%)

11 (58%)

ns (p = 1.00)

Age in years (mean)

49.6 (14.8)

39.2 (10.6)

p = 0.002

BMI (mean)

25.8 (2.6)

26.3 (3.8)

ns (p = 0.51)

Cups of coffee per day (mean)

3.0 (2.2)

3.4 (3.0)

ns (p = 0.72)

Smoking (daily/past/never) (no)

13/17/28

6/11/2

p = 0.029

Duration of reflux symptoms in years (mean)

7.7 (7.7)

9.0 (8.9)

ns (p = 0.55)

Esophagitis (NERD/LAgrA/LAgrB) (no)

10/28/20

2/9/8

ns (p = 0.46)

Hiatal hernia (no)

21 (36%)

6 (32%)

ns (p = 0.78)

Symptom score at inclusion (mean)

11.2 (3.6)

11.9 (5.0)

ns (p = 0.49)

Symptom score at the end of treatment (mean)

6.1 (3.4)

9.5 (4.8)

p = 0.004

Weeks of satisfactory relief (mean proportion)

94.6% (13.6)

18.7% (32.0)

p < 0.001

Prefer same drug after the trial (no)

48 (83%)

1 (5%)

p < 0.001

Prefer regular treatment (no)

7 (12%)

5 (26%)

ns (p = 0.15)

Rapid relapse of symptoms (no)

15 (26%)

11 (58%)

p = 0.023

Delayed onset of effect (no)

9 (16%)

5 (26%)

ns (p = 0.32)

Too many tablets (no)

6 (10%)

7 (37%)

p = 0.013

Diarrhoea (no)

6 (10%)

1 (5%)

ns (p = 0.67)

  1. The results are given as number of patients (proportion in brackets) or mean (standard deviation in brackets).
  2. BMI: Body mass index.
  3. NERD: Non erosive reflux disease.
  4. LAgrA: Los Angeles grade A.
  5. LAgrB: Los Angeles grade B